Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | CDK1 | P06493 | 1/20 | 0.37 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.36 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.36 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.36 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.36 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.36 |
| ▸ | ENGASE | Q8NFI3 | 1/20 | 0.35 |
| ▸ | XDH | P47989 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12650543 | 1.00 | SLC6A2 (0.37) | SLC6A2MEN1KMT2AACHEPTPN1 | |
| SCHEMBL12798046 | 0.94 | MEN1 (0.40) | SLC6A2MEN1KMT2APTPN1L3MBTL1 | |
| SCHEMBL12650358 | 0.94 | MEN1 (0.40) | SLC6A2MEN1KMT2APTPN1L3MBTL1 | |
| SCHEMBL12650357 | 0.91 | ACHE (0.41) | SLC6A2MEN1KMT2AACHEPTPN1 | |
| SCHEMBL16317613 | 0.90 | TSHR (0.41) | SLC6A2KMT2ALGALS9LGALS1LGALS3 | |
| SCHEMBL16317615 | 0.89 | ALDH1A1 (0.41) | SYNJ2LGALS9LGALS1LGALS3LGALS7; LGALS7B | |
| SCHEMBL12604172 | 0.83 | SLC6A2 (0.41) | SLC6A2MEN1KMT2APTPN1L3MBTL1 | |
| SCHEMBL4633222 | 0.81 | MEN1 (0.41) | MEN1KMT2AL3MBTL1 | |
| SCHEMBL12604168 | 0.76 | PTPN1 (0.42) | SLC6A2MEN1KMT2APTPN1L3MBTL1 | |
| SCHEMBL16579690 | 0.76 | MEN1 (0.38) | MEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7902158-B2 | Polysulfated glycosides and salts thereof | Ivax Drug Research Ltd. (HU) | 2011-03-08 | — | — | US | disclosed |
| US-7902158-B2 | Polysulfated glycosides and salts thereof | Ivax Drug Research Ltd. (HU) | 2011-03-08 | — | — | US | disclosed |
| US-20070281893-A1 | Polysulfated Glycosides And Salts Thereof | IVAX DRUG RESEARCH INSTITUTE LTD (HU) | 2007-12-06 | — | — | US | disclosed |
| US-20070281893-A1 | Polysulfated Glycosides And Salts Thereof | IVAX DRUG RESEARCH INSTITUTE LTD (HU) | 2007-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070281893-A1 | Polysulfated Glycosides And Salts Thereof | CFTR, AREG, STS | SLC6A2 2378/4885MEN1 4865/4885KMT2A 3112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.